PTCE Compounding 2

Question 1

Which beyond-use date (BUD) applies to a non-aqueous compounded preparation stored at room temperature?

Accepted Answer

6 months or the earliest manufacturer expiration date, whichever is sooner

Answer

14 days

Answer

30 days

Answer

1 year

Question 2

What is the primary purpose of a levigating agent in ointment preparation?

Accepted Answer

To reduce particle size and improve uniform distribution of the active ingredient

Answer

To increase viscosity of the base

Answer

To act as a preservative

Answer

To lower the melting point of the ointment

Question 3

A pharmacy technician is preparing a 2% hydrocortisone cream using a 10% hydrocortisone cream and a plain cream base. What compounding method is being used?

Accepted Answer

Geometric dilution

Answer

Trituration

Answer

Levigation

Answer

Fusion

Question 4

Which USP chapter governs sterile compounding quality standards for pharmacy-prepared products?

Accepted Answer

USP <797>

Answer

USP <795>

Answer

USP <800>

Answer

USP <1151>

Question 5

When compounding a suppository using the fusion method, which step is critical to prevent sedimentation of the active drug?

Accepted Answer

Continuously stirring the mixture until it congeals

Answer

Heating the base to at least 100°C

Answer

Adding the drug after the base solidifies

Answer

Refrigerating immediately after pouring

Question 6

Which type of water is required for sterile compounding preparations?

Accepted Answer

Sterile Water for Injection (SWFI)

Answer

Distilled water

Answer

Purified water

Answer

Tap water filtered through 0.45 micron

Question 7

A compounded preparation's label must include all of the following EXCEPT:

Accepted Answer

The prescriber's DEA number

Answer

Beyond-use date

Answer

Directions for use

Answer

Name and strength of the active ingredient